- AREV Nanotec Brands (AREV) has retained Dr. Uma V. A. Dhanabalan to join the Advisory Board to consult on AREV product development sciences
- Dr. Dhanabalan is a highly respected physician, graduated from UMDNJ, Newark, New Jersey, trained in Family Medicine at MUSC in Charleston, South Carolina, and earned her Master’s in Public Health
- Her goal is to “Educate, Embrace & Empower” her patients and the public with safe and effective alternative treatment options, including cannabis
- AREV NanoTech has issued 50 thousand stock options to Directors, Officers and Consultants of AREV Nanotec at C$0.275 for a period of 5 years from the issuance dated
- AREV NanoTec Brands (AREV) is down 9.09 per cent and is trading at C$0.25 at 12:51 pm EST
AREV Nanotec Brands (AREV) has retained Dr. Uma V. A. Dhanabalan to join the Advisory Board to consult on AREV product development sciences.
Dr. Uma V.A. Dhanabalan will also act as a product brand ambassador at events and consulting through clinics.
Dr. Dhanabalan is a highly respected physician and a graduate of UMDNJ, Newark, New Jersey. Dr. Dhanabalan trained in Family Medicine at MUSC in Charleston, South Carolina, and earned her Master’s in Public Health.
She is trained in Occupational & Environmental Medicine and completed her Fellowship in Heavy Metals at Harvard School of Public Health in Boston, Massachusetts.
She is a Fellow of the American Academy of Family Physicians, a Diplomat Certified in Cannabinoid Medicine and a Medical Review Officer.
Dr. Dhanabalan is the Founder/CEO of Global Health & Hygiene Solutions, LLC, whose mission is to promote wellness and prevent illness locally and globally.
She runs an Independent practice at Uplifting Health & Wellness in Cambridge, MA, where she provides tools to all ages from various backgrounds.
Her goal is to “Educate, Embrace & Empower” her patients and the public with safe and effective alternative treatment options, including cannabis.
Dr. Dhanabalan believes that “Cannabis is not for everyone, yet it should be the first-line option, not the last resort,”™ said Dr. Dhanabalan.
CEO, Mike Withrow commented, “We welcome Dr. Dhanabalan to the AREV Nanotec Scientific Advisory Board. [She is an] early leader in cannabinoid medicine and has helped thousands of people overcome illness.”
“We are fortunate to have her advise us on the interworking of our products within the human body. This will lead us to deliver efficacious products people can trust to maintain good health,” he concluded.
Dr. Dhanabalan commented, “I am excited to be part of the AREV NanoTec team. I am here to use my experience and work together with AREV’s technology to create safe, effective products to improve health and wellness around the globe.”
AREV NanoTech has issued 50 thousand stock options to Directors, Officers and Consultants of AREV Nanotec at C$0.275 for a period of 5 years from the issuance dated.
These options will vest immediately.
AREV NanoTec Brands produces and sells functional ingredients made via its proprietary extraction systems. Its model is to toll the extraction of targeted essential and practical oils and license its formulations to Licensed Producers in Canada.
AREV NanoTec Brands (AREV) is down 9.09 per cent and is trading at C$0.25 at 12:51 pm EST.
